TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
9.55
-0.13 (-1.34%)
At close: Mar 18, 2026, 4:00 PM EDT
9.22
-0.33 (-3.46%)
After-hours: Mar 18, 2026, 7:28 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $8.76 million as of March 18, 2026. Its market cap has increased by 535.23% in one year.
Market Cap
8.76M
Enterprise Value
5.92M
1-Year Change
535.23%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $8.76M, a decrease of -81.71%. That is a compound annual growth rate of -30.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 8.88M | 41.73% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 9.87M |
| Quantum BioPharma | 9.77M |
| BioAtla | 9.71M |
| Ernexa Therapeutics | 9.45M |
| SeaStar Medical Holding | 9.23M |
| Imunon | 9.18M |
| Iterum Therapeutics | 9.11M |
| Addex Therapeutics | 8.40M |